LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study
LOAd703(一种基于溶瘤病毒的免疫刺激基因疗法)联合化疗治疗不可切除或转移性胰腺癌(LOKON001):一项非随机、单中心、1/2期研究的第1组结果
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(24)00079-2
Musher, Benjamin L; Rowinsky, Eric K; Smaglo, Brandon G; Abidi, Wasif; Othman, Mohamed; Patel, Kalpesh; Jawaid, Salmaan; Jing, James; Brisco, Amanda; Leen, Ann M; Wu, Mengfen; Sandin, Linda C; Wenthe, Jessica; Eriksson, Emma; Ullenhag, Gustav J; Grilley, Bambi; Leja-Jarblad, Justyna; Hilsenbeck, Susan G; Brenner, Malcolm K; Loskog, Angelica S I